Medexus Pharmaceuticals Inc. (TSX:MDP)
5.71
-0.26 (-4.36%)
Nov 19, 2026, 4:00 PM EST
Medexus Pharmaceuticals Revenue
Medexus Pharmaceuticals had revenue of $29.10M USD in the quarter ending September 30, 2026, with 17.62% growth. This brings the company's total for the last twelve months to $107.66M, up 3.42% year-over-year. In the fiscal year ending March 31, 2026, Medexus Pharmaceuticals had annual revenue of $99.33M, down -8.31%. That makes Medexus Pharmaceuticals the 22,185th largest company in the world by revenue and 417th in Canada.
Revenue (ttm)
$107.66M
Revenue Growth
+3.42%
P/S Ratio
1.22
Revenue / Employee
$1.20M
Employees
90
Market Cap
178.08M CAD
Revenue by Geography
- United States 74.74M 75.2%
- Canada 24.59M 24.8%
Fiscal year ended Mar 31, 2026 See the full Medexus Pharmaceuticals breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 99.33M | -9.00M | -8.31% |
| Mar 31, 2025 | 108.33M | -4.72M | -4.18% |
| Mar 31, 2024 | 113.05M | 4.96M | 4.59% |
| Mar 31, 2023 | 108.10M | 31.40M | 40.93% |
| Mar 31, 2022 | 76.70M | -2.96M | -3.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 924.67M |
| TerrAscend | 379.07M |
| Organigram Global | 309.18M |
| Canopy Growth | 308.32M |
| Cannara Biotech | 117.33M |
| HLS Therapeutics | 80.76M |
| Cipher Pharmaceuticals | 70.26M |
| Grown Rogue International | 57.07M |
Medexus Pharmaceuticals News
- 6 days ago - What Medexus Pharmaceuticals (MDP) Said on Its Q2 Earnings Call - MarketBeat
- 7 days ago - Medexus Pharmaceuticals Earnings Call Transcript: Q2 2027 - Transcripts
- 7 days ago - Medexus Pharmaceuticals Earnings release: Q2 2027 - Filings
- 7 days ago - Medexus Pharmaceuticals Report: Q2 2027 - Filings
- 7 days ago - Medexus Pharmaceuticals MD&A: Q2 2027 - Filings
- 7 days ago - Medexus Announces Strong Fiscal Q2 2027 Results Driven By Record Product-Level Performance of GRAFAPEX (Treosulfan) for Injection - Newsfile Corp
- 15 days ago - Medexus Schedules Second Fiscal Quarter 2027 Conference Call - Newsfile Corp
- 22 days ago - Medexus Pharmaceuticals Transcript: Planet MicroCap Showcase: Toronto 2026 - Transcripts